{"id":"LLY","quote":{"symbol":"LLY","name":"Eli Lilly and Company","price":547.99,"changesPercentage":-1.067,"change":-5.91,"dayLow":547.04,"dayHigh":557.745,"yearHigh":557.745,"yearLow":296.32,"marketCap":520204153898,"priceAvg50":482.9218,"priceAvg200":398.28485,"exchange":"NYSE","volume":1634937,"avgVolume":2753436,"open":555.01,"previousClose":553.9,"eps":7.2,"pe":76.11,"earningsAnnouncement":"2023-11-02T12:30:00.000+0000","sharesOutstanding":949294976,"timestamp":1693425789},"priceChange":{"symbol":"LLY","1D":-1.067,"5D":-0.29838255,"1M":19.52321,"3M":28.2628,"6M":76.07802,"ytd":50.13836,"1Y":78.47512,"3Y":269.29038,"5Y":419.52029,"10Y":966.1284,"max":13430.61728},"profile":{"symbol":"LLY","price":547.99,"beta":0.349497,"volAvg":2753436,"mktCap":520204153898,"lastDiv":4.52,"range":"296.32-557.745","changes":-5.91,"companyName":"Eli Lilly and Company","currency":"USD","cik":"0000059478","isin":"US5324571083","cusip":"532457108","exchange":"New York Stock Exchange","exchangeShortName":"NYSE","industry":"Drug Manufacturersâ€”General","website":"https://www.lilly.com","description":"Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.","ceo":"Mr. David A. Ricks","sector":"Healthcare","country":"US","fullTimeEmployees":"39000","phone":"317 276 2000","address":"Lilly Corporate Center","city":"Indianapolis","state":"IN","zip":"46285","dcfDiff":23.2584,"dcf":365.358,"image":"https://financialmodelingprep.com/image-stock/LLY.png","ipoDate":"1972-06-01","defaultImage":false,"isEtf":false,"isActivelyTrading":true,"isAdr":false,"isFund":false}}